Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Endothelin-1 stimulates human adipocyte lipolysis through the ETA receptor

International Journal of Obesity volume 33, pages 67–74 (2009)Cite this article

Abstract

Objective:

Levels of the vascular peptide endothelin-1 (ET-1) are significantly elevated in obesity. Adipose tissue-derived ET-1 attenuates insulin-mediated antilipolysis in human visceral adipocytes through the activation of the ET receptor B (ETBR), thereby linking ET-1 to insulin resistance. Whether ET-1 has direct effects on lipolysis in human adipocytes is not known.

Research design and subjects:

Endothelin-1 receptor (ETR) mRNA expression was determined by quatitative PCR in 130 non-obese and obese subjects. ET-1 mRNA in different adipose tissue regions was also assessed. ETR protein expression was analyzed by western blotting in 37 subjects. The effect of ET-1 on lipolysis was assessed in freshly isolated adipocytes and in vitro differentiated adipocytes from human donors.

Results:

Freshly isolated human adipocytes incubated with different concentrations of ET-1 showed no acute effect on lipolysis. In contrast, a 24 h incubation in primary cultures of human adipocytes resulted in a significant 50% increase in lipolysis. This effect was concentration dependent and could be mimicked by an agonist of the ETA receptor but not with a selective ETBR agonist. Adipocyte differentiation was not affected by any of the agonists. In subcutaneous (s.c.) adipose tissue from 19 non-obese and 18 obese subjects, the protein expression of ETAR was significantly higher in obese subjects whereas there was no difference in ETBR expression. Interestingly, the differences in protein expression were not observed at the mRNA level as ETAR expression was similar between lean and obese subjects.

Conclusion:

Long-term but not acute incubation of human adipocytes with ET-1 results in a significant increase in lipolysis. This appears to be mediated through the activation of ETAR, demonstrating a yet another receptor-specific effect of ET-1. In addition, the protein expression of ETAR is increased in s.c. adipose tissue in obesity, possibly through post-transcriptional mechanisms. An increased effect of ET-1 could be a mechanism that contributes to increased basal lipolysis in human obesity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Fantuzzi G, Mazzone T . Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27: 996–1003.

    Article  CAS  PubMed  Google Scholar 

  2. Sowers JR . Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8A): 37S–41S.

    Article  CAS  PubMed  Google Scholar 

  3. Arner P . The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003; 14: 137–145.

    Article  CAS  PubMed  Google Scholar 

  4. Arner P . Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005; 19: 471–482.

    Article  CAS  PubMed  Google Scholar 

  5. Langin D . Control of fatty acid and glycerol release in adipose tissue lipolysis. C R Biol 2006; 329: 598–607; discussion 653–555.

    Article  CAS  PubMed  Google Scholar 

  6. Sokolovsky M . Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol Ther 1995; 68: 435–471.

    Article  CAS  PubMed  Google Scholar 

  7. Bouallegue A, Daou GB, Srivastava AK . Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 2007; 5: 45–52.

    Article  CAS  PubMed  Google Scholar 

  8. Sokolovsky M . Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades. Cell Mol Neurobiol 1995; 15: 561–571.

    Article  CAS  PubMed  Google Scholar 

  9. Juan CC, Chang CL, Lai YH, Ho LT . Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005; 288: E1146–E1152.

    Article  CAS  PubMed  Google Scholar 

  10. van Harmelen V, Eriksson A, Astrom G, Wahlen K, Naslund E, Karpe F et al. Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis. Diabetes 2008; 57: 378–386.

    Article  CAS  PubMed  Google Scholar 

  11. Juan CC, Chang LW, Huang SW, Chang CL, Lee CY, Chien Y et al. Effect of endothelin-1 on lipolysis in rat adipocytes. Obesity (Silver Spring) 2006; 14: 398–404.

    Article  CAS  Google Scholar 

  12. Ryden M, Arner P . Fat loss in cachexia—is there a role for adipocyte lipolysis? Clin Nutr 2007; 26: 1–6.

    Article  CAS  PubMed  Google Scholar 

  13. Arner P, Stenson BM, Dungner E, Naslund E, Hoffstedt J, Ryden M et al. Expression of STAMP2 in human adipose tissue associates with adiposity and insulin resistance. J Clin Endocrinol Metab 2008; 93: 2249–2254.

    Article  CAS  PubMed  Google Scholar 

  14. van Harmelen V, Skurk T, Hauner H . Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med 2005; 107: 125–135.

    CAS  PubMed  Google Scholar 

  15. Mairal A, Langin D, Arner P, Hoffstedt J . Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia 2006; 49: 1629–1636.

    Article  CAS  PubMed  Google Scholar 

  16. Hellmer J, Marcus C, Sonnenfeld T, Arner P . Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 1992; 75: 15–20.

    CAS  PubMed  Google Scholar 

  17. Ryden M, Dicker A, van Harmelen V, Hauner H, Brunnberg M, Perbeck L et al. Mapping of early signaling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells. J Biol Chem 2002; 277: 1085–1091.

    Article  CAS  PubMed  Google Scholar 

  18. Ryden M, Jocken J, van Harmelen V, Dicker A, Hoffstedt J, Wiren M et al. Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis. Am J Physiol Endocrinol Metab 2007; 292: E1847–E1855.

    Article  CAS  PubMed  Google Scholar 

  19. Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 2001; 25: 402–408.

    Article  CAS  PubMed  Google Scholar 

  20. Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A et al. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997; 105 (Suppl 2): 38–40.

    CAS  PubMed  Google Scholar 

  21. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH . Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 1992; 5: 161–166.

    Article  CAS  PubMed  Google Scholar 

  22. Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G et al. Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 1996; 9: 1186–1191.

    Article  CAS  PubMed  Google Scholar 

  23. Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K et al. Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 2002; 15: 967–972.

    Article  CAS  PubMed  Google Scholar 

  24. Touyz RM, Schiffrin EL . Role of endothelin in human hypertension. Can J Physiol Pharmacol 2003; 81: 533–541.

    Article  CAS  PubMed  Google Scholar 

  25. Ryden M, Arner P . Tumour necrosis factor-alpha in human adipose tissue—from signalling mechanisms to clinical implications. J Intern Med 2007; 262: 431–438.

    Article  CAS  PubMed  Google Scholar 

  26. Rossi GP, Andreis PG, Colonna S, Albertin G, Aragona F, Belloni AS et al. Endothelin-1[1-31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth. J Clin Endocrinol Metab 2002; 87: 322–328.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms Eva Sjölin for excellent technical assistance. This study was supported by grants from the Swedish Research Council, Swedish Medical Association, Karolinska Institutet and the Söderberg foundation. This study was supported by the European Union [HEPADIP (LSHM-CT-2005-018734), ADAPT (HEALTH-F2-2008-201100], NordForsk. (SYSDIET-070014) and COST -action BM0602.

Author information

Authors and Affiliations

  1. Department of Medicine (H7), Karolinska Institutet at the Karolinska University Hospital, Stockholm, Sweden

    A K S Eriksson, V van Harmelen, B M Stenson, G Åström, K Wåhlén, J Laurencikiene & M Rydén

Authors
  1. A K S Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V van Harmelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B M Stenson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Åström
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Wåhlén
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Laurencikiene
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Rydén
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Rydén.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eriksson, A., van Harmelen, V., Stenson, B. et al. Endothelin-1 stimulates human adipocyte lipolysis through the ETA receptor. Int J Obes 33, 67–74 (2009). https://doi.org/10.1038/ijo.2008.212

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.212

Keywords

This article is cited by

Search

Advanced search

Quick links